ACCELERATE DIAGNOSTICS INC AXDX 2.5 03.15.23
NOTE 2.500% 3/1 · US DOMESTIC · CUSIP 00430HAB8
9
institutional holders
3.0m
shares reported held*
$38.8mreported value*
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $12.93.
Holders, Q3 2022
| Manager | Shares | Change |
|---|---|---|
| Indaba Capital Management, L.P. 3.16% of their portfolio | 22.2m $20.6m | — |
| ROYAL BANK OF CANADA 0.00% of their portfolio | 5.5m $5.0m | — |
| WOLVERINE ASSET MANAGEMENT LLC 0.05% of their portfolio | 4.0m $3.6m | — |
| Bruce & Co., Inc. 0.74% of their portfolio | 3.0m $2.7m | — |
| JANE STREET GROUP, LLC 0.01% of their portfolio | 3.0m $2.7m | — |
| PenderFund Capital Management Ltd. 0.75% of their portfolio | 1.9m $2.4m | — |
| CREDIT SUISSE AG/ 0.00% of their portfolio | 1.0m $1.0m | — |
| INGALLS & SNYDER LLC 0.04% of their portfolio | 769.0k $699.0k | — |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | — |